Christopher B. Ehrlich - 25 Aug 2021 Form 4 Insider Report for eFFECTOR Therapeutics, Inc.

Role: Director
Signature: /s/ Michael Byrnes, Attorney-in-Fact for Chris Ehrlich
Issuer symbol: N/A
Transactions as of: 25 Aug 2021
Net transaction value: $0
Form type: 4
Filing time: 27 Aug 2021, 18:53:30 UTC
Next filing: 05 Oct 2021
SEC filing: View on sec.gov

Key filing fact

Christopher B. Ehrlich filed Form 4 for eFFECTOR Therapeutics, Inc. on 27 Aug 2021.

Key facts

This page summarizes Christopher B. Ehrlich's Form 4 filing for eFFECTOR Therapeutics, Inc..
6 reported transactions and 4 derivative rows are listed below.
Filing timestamp: 27 Aug 2021, 18:53.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Reported transactions

EFTR transaction

Common Stock

Conversion of derivative security

Transaction value: $0
Shares: +142,168
Change %
Price: $0.000000
Shares after: 142,168
Date: 25 Aug 2021
Ownership: By Locust Walk Partners LLC
Footnotes: F1

EFTR transaction

Common Stock

Conversion of derivative security

Transaction value: $0
Shares: +1,034
Change %
Price: $0.000000
Shares after: 1,034
Date: 25 Aug 2021
Ownership: By Locust Walk Partners LLC
Footnotes: F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

EFTR transaction Derivative

Class B Common Stock

Disposed to Issuer

Transaction value: $0
Shares: -132,832
Change %: -48%
Price: $0.000000
Shares after: 142,168
Date: 25 Aug 2021
Ownership: By Locust Walk Partners LLC
Underlying class: Common Stock
Underlying amount: 132,832
Exercise price
Footnotes: F1, F3, F4, F5

EFTR transaction Derivative

Class B Common Stock

Conversion of derivative security

Transaction value
Shares: -142,168
Change %: -100%
Price
Shares after: 0
Date: 25 Aug 2021
Ownership: By Locust Walk Partners LLC
Underlying class: Common Stock
Underlying amount: 142,168
Exercise price
Footnotes: F1, F3

EFTR transaction Derivative

Class B Common Stock

Disposed to Issuer

Transaction value: $0
Shares: -966
Change %: -48%
Price: $0.000000
Shares after: 1,034
Date: 25 Aug 2021
Ownership: By Locust Walk Partners LLC(
Underlying class: Common Stock
Underlying amount: 966
Exercise price
Footnotes: F2, F3, F4, F5

EFTR transaction Derivative

Class B Common Stock

Conversion of derivative security

Transaction value
Shares: -1,034
Change %: -100%
Price
Shares after: 0
Date: 25 Aug 2021
Ownership: By Locust Walk Partners LLC
Underlying class: Common Stock
Underlying amount: 1,034
Exercise price
Footnotes: F2, F3

^* indicates a reported price that failed the local validity check.

Explanation of Responses:

Id	Content
F1	Represents shares held directly by the Sponsor, of which Locust Walk Partners LLC ("LWP") is a member. LWP has allocated these shares to the reporting person.
F2	Represents shares held directly by the Sponsor, of which LWP is a member. LWP has allocated these shares to the reporting person's spouse.
F3	On August 25, 2021, pursuant to that certain Agreement and Plan of Merger, dated as of May 26, 2021 (the "Merger Agreement"), by and among the Issuer (f/k/a Locust Walk Acquisition Corp.), Locust Walk Merger Sub, Inc. ("Merger Sub"), and eFFECTOR Therapeutics, Inc. ("Old eFFECTOR"), Merger Sub merged with and into Old eFFECTOR with Old eFFECTOR surviving as a wholly owned subsidiary of the Issuer (the "Merger"). In connection with and upon consummation of the Merger, each of the Issuer's outstanding shares of Class B Common Stock automatically converted into one share of Class A Common Stock and such shares of Class A Common Stock were automatically reclassified in shares of common stock.
F4	Pursuant to an agreement by and between the Issuer and Locust Walk Sponsor, LLC (the "Sponsor"), concurrent with the consummation of the Merger, these shares of Class B Common Stock were forfeited to the Issuer immediately prior to the Merger.
F5	As a former principal of the manager of the Sponsor, the reporting person previously reported all securities held by the Sponsor. As of the date hereof, the reporting person is no longer a principal of the entity with control over the securities held by the Sponsor, accordingly, this report only includes securities to the extent of the reporting person's and his spouse's pecuniary interest therein.